Treatment of alcohol use disorders in adolescents

Journal of Psychiatric Practice

Volumn 9, Issue 3, 2003, Pages 195-208

  Mack, Avram H ^a   Frances, Richard J ^a  

^a SILVER HILL HOSPITAL   (United States)

Author keywords

Adolescents; Alcohol abuse; Alcohol dependence; Alcohol use disorders; Assessment; Cognitive behavioral therapy; Comorbidity; Interpersonal psychotherapy; Medications; Psychoeducation; Psychotherapy; Skills training; Substance use disorders; Suicide; Treatment

Indexed keywords

ACAMPROSATE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DISULFIRAM; LITHIUM; NALTREXONE; OPIATE; SEROTONIN UPTAKE INHIBITOR;

ABSTINENCE; ADOLESCENCE; ALCOHOL ABUSE; ALCOHOLICS ANONYMOUS; ALCOHOLISM; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CHILD PSYCHIATRY; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG INDICATION; FAMILY THERAPY; HOSPITAL CARE; HUMAN; MOTIVATION; OUTPATIENT CARE; PATIENT EDUCATION; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; SOCIAL ADAPTATION; SUICIDE; TREATMENT PLANNING; VIOLENCE;

EID: 0038311634     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200305000-00003     Document Type: Article

References (96)

1. Cornelius JR, Bukstein OG, Birmaher B, et al. Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial. Addict Behav 2001;26:735-9.
2. Clark DB, Pollock N, Bukstein, et al. Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry 1997;36:1195-1202.
3. Clark DB, Lesnick L, Hegedus AM. Traumas and other adverse life events in adolescents with alcohol abuse and dependence. J Am Acad Child Adolesc Psychiatry 1997;36:1744-51.
4. Kandel DB, ed. Stages and pathways of drug involvement: Examining the gateway hypothesis. Cambridge: Cambridge University Press, 2002.
5. Substance Abuse and Mental Health Services Administration (SAMHSA). Summary of findings from the 2000 National Household Survey on Drug Abuse (NHSDA Series: H-13, DHHS Publication No. SMA 01-3549). Rockville, MD: SAMHSA; 2001.
6. Johnston LD, O'Malley PM, Bachman JG. Monitoring the future national results on adolescent drug use: Overview of key findings, 2000. (NIH Publication No. 01-4923). Bethesda, MD: National Institute on Drug Abuse; 2001.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
8. Harrison PA, Fulkerson JA, Beebe TJ. DSM-IV substance use disorder criteria for adolescents: A critical examination based on a statewide school survey. Am J Psychiatry 1998;155:486-92.
9. Johnston LD, O'Malley PM, Bachman JG. Ecstasy use among American teens drops for the first time in recent years, and overall drug and alcohol use also decline in the year after 9/11. Ann Arbor, MI: University of Michigan News and Information Services; December 16, 2002. Available at www.monitoringthe-future.org (accessed 02/17/03).
10. Wagner EF, Brown SA, Monti PM, et al. Innovations in adolescent substance abuse intervention. Alcohol Clin Exp Res 1999;23:236-49.
11. Kaminer Y. Contingency management reinforcement procedures for adolescent substance abuse. J Am Acad Child Adolesc Psychiatry 2000;39:1324-6.
12. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids. Am J Psychiatry 1995;152:1-59.
13. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 1997;36(suppl 10):140s-156s.
14. American Academy of Pediatrics. Tobacco, alcohol, and other drugs: The role of the pediatrician in prevention and management of substance abuse. Pediatrics 1998;101:125-8.
15. Treatment of adolescents with substance use disorders (TIPS 32). Rockville, MD: Center for Substance Abuse Treatment; 1999.
16. Mack AH, Franklin JE, Frances RJ. Concise guide to the treatment of alcoholism and addictions. Washington, DC: American Psychiatric Press; 2001.
17. Weinberg NZ, Rahdert E, Colliver JD, et al. Adolescent substance abuse: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1998;37:252-61.
18. Mack AH, Franklin JE, Frances RJ. Substance related disorders. In: Hales R, Yudofsky S, eds. American Psychiatric Press textbook of psychiatry, 4th Ed. Washington, DC: American Psychiatric Press; 2003:309-77.
19. Jainchill N. Substance dependency treatment for adolescents: Practice and research. Substance Use Misuse 2000;35:2031-60.
20. Chatlos J. Recent trends and a developmental approach to substance abuse in adolescents. Child Adolesc Clin North Am 1996;5:1-27.
21. Jaffe SL, Simkin DR. Alcohol and drug abuse in children and adolescents. In: Lewis M, ed. Child and adolescent psychiatry: A comprehensive textbook. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002:895-911.
22. Chung T, Martin CS, Armstrong TD, et al. Prevalence of DSM-IV alcohol diagnoses and symptoms in adolescent community and clinical samples. J Am Acad Child Adolesc Psychiatry 2002;41:546-54.
23. Centers for Disease Control. Involvement by young drivers in fatal alcohol-related motor vehicle crashes - United States, 1982-2001. MMWR 2002;51:1089-91.
24. Chung T, Martin CS. Classification and course of alcohol problems among adolescents in addictions. Alcohol Clin Exp Res 2001;25:1734-42.
25. D'Amico EJ, Metrik J, McCarthy DM, et al. Progression into and out of binge drinking among high school students. Psychol Addict Behav 2001;15:341-9.
26. Brown SA, Vik PW, Creamer VA. Characteristics of relapse following adolescent substance abuse treatment. Addictive Behavior 1989;14:291-300.
27. Schuckit M. Alcohol Medical Scholars Program website. www.alcoholmedicalscholars.org (accessed 2/7/03).
28. Cambor RL, Millman RB. Alcohol and drug abuse in adolescents. In: Lewis M, ed. Child and adolescent psychiatry: A comprehensive textbook. 2nd ed. Baltimore: Williams and Wilkins; 1995:736-52.
29. Martin SE, Snyder LB, Hamilton M, et al. Alcohol advertising and youth. Alcohol Clin Exp Res 2002;26:900-6.
30. Kandel DB, Johnson JG, Bird HR, et al. Psychiatric comorbidity among adolescents with substance use disorders: Findings from the MECA study. J Am Acad Child Adolesc Psychiatry 1999; 38:693-9.
31. Cloninger RC, Sigvardson S, Bohman M. Childhood personality predicts alcohol abuse in young adults. Alc Clin Exp Res 1988;12:494-505.
32. Cloninger CR, Dinwiddie S, Reich T. Epidemiology and genetics in alcoholism. In Tasman A, Hales RE, Frances AJ, eds: Review of Psychiatry. Washington, DC: American Psychiatric Press; 1989:293-308.
33. Schwartz RH. Testing for drugs of abuse: Controversies and techniques. Adolesc Med 1993;4:353-70.
34. Dell ML. Medical conditions in child and adolescent substance abuse: Medical complications, pain management, and emergency treatment. Child Adolesc Psychiatr Clin North Am 1996;5:123-48.
35. Kaufman J, Birmaher B, Brint D, et al. Schedule for Affective Disorders and Schizophrenia for school age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-8.
36. Shaffer D, Fisher P, Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA study. J Am Acad Child Adolesc Psychiatry 1996;35:865-77.
37. Ewing JA. Detecting alcoholism: The CAGE Questionnaire. JAMA 1984;252:1905-7.
38. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV (SCID-1): (User's Guide and Interview) Research Version. New York: Biometrics Research Department, New York Psychiatric Institute; 1995.
39. Martin CS, Pollock NK, Bukstein OG, et al. Inter-rater reliability of the SCID alcohol and substance use disorder section among adolescents. Drug and Alcohol Dependence 2000;59:173-6.
40. Kaminer Y, Bukstein O, Tarter RE. The Teen-Addiction Severity Index: Rationale and reliability. Int J Addiction 1991;26:219-26.
41. Hser Y-I, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry 2001;58:689-95.
42. Grella CE, Hser Y-I, Joshi V, et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001;189:384-92.
43. Marlatt GA, Gordon JR. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 1985.
44. Dakoff GA, Tejeda M, Liddle HA. Predictors of engagement in adolescent drug abuse treatment. J Am Acad Child Adolesc Psychiatry 2001;40:274-81.
45. Kaminer Y, Tarter RE, Bukstein OG, et al. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 1992;31:1046-9.
46. Blood L, Cornwall A. Pretreatment variables that predict completion of an adolescent substance abuse treatment program. J Nerv Ment Dis 1994;182:14-9.
47. Rivers SM, Greenbaum RL, Goldberg E. Hospital-based adolescent substance abuse treatment: Comorbidity, outcomes, and gender. J Nerv Ment Dis 2001;189:229-37.
48. American Society of Addiction Medicine. Patient placement criteria for the treatment of substance-related disorders, 2nd edition. Chevy Chase: American Society of Addiction Medicine; 1996.
49. Weiner DA, Abraham ME, Lyons J. Clinical characteristics of youths with substance use problems and implications for residential treatment. Psychiatr Serv 2001;52:793-9.
50. Jainchill N, Hawke J, Deleon G, et al. Adolescents in therapeutic communities: One year posttreatment outcomes. J Psychoactive Drugs 2000;32:81-94.
51. Stewart DG, Brown SA. Withdrawal and dependency symptoms among adolescent alcohol and drug abusers. Addiction 1995;90:627-35.
52. Erickson PG. Harm reduction: What it is and what it is not. Drug Alcohol Rev 1995;14:283-85.
53. Riddle M, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry 2001;42:73-90.
54. O'Malley SS, Froehlich JC. Advances in the use of naltrexone: An integration of preclinical and clinical findings. Recent Dev Alcohol 2003;16:217-45.
55. Krystal JH, Cramer JA, Krol WF, et al. Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001;345: 1734-9.
56. Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebo-controlled study. Arch Gen Psychiatry. 2003;60:92-9.
57. Frances R, Mack A, Borg L, et al. Psychodynamics and the treatment of substance-related disorders. In: Gabbard G, ed. Treatment of psychiatric disorders, 3rd Ed. Washington, DC: American Psychiatric Press; 2001:829-37.
58. Azrin NH, Donohue B, Besalel VA, et al. Youth drug abuse treatment: A controlled outcome study. J Child Adolesc Subst Abuse 1994;3:1-16.
59. Fisher MS, Bentley KJ. Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder. Psychiatr Serv 1996;47:1244-50.
60. Kelly JF, Myers MG, Brown SA. A multivariate process model of adolescent 12-step attendance and substance use outcome following inpatient treatment. Psychol Addict Behav 2000;14: 376-89.
61. Kaminer Y, Burleson J, Blitz C, et al. Psychotherapies for adolescent substance abusers: A pilot study. J Nerv Ment Dis 1998; 186:684-90.
62. Linehan MM, Schmidt H 3rd, Dimeff LA, et al. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 1999;8:279-92.
63. Kelly JF, Myers MG, Brown SA. Do adolescents affiliate with 12-step groups? A multivariate process model of effects. J Stud Alcohol 2002;63:293-304.
64. Ozechowski TJ, Liddle HA. Family-based therapy for adolescent drug abuse: Knowns and unknowns. Clin Child Fam Psychology Rev 2000;3:269-99.
65. Stanton MD, Shadish WR. Outcome, attrition and family/couples treatment for drug abuse: A meta-analysis and review of the controlled, comparative studies. Psychol Bull 1997;122:170-91.
66. Liddle HA, Dakof GA. Family-based treatment for adolescent drug use: State of the science. In: Rahdert E, Czechowicz D, eds. Adolescent drug abuse: Clinical assessment and therapeutic interventions (NIDA Research Monograph No. 156, NIH Publication 1995 No. 95-3908) Rockville, MD: National Institute on Drug Abuse; 1995: 218-54.
67. Schmidt SE, Liddle HA, Dakof GA. Changes in parenting practices and adolescent drug abuse during multidimensional family therapy. Journal of Family Psychology 1996;10:12-27.
68. Joanning H, Quinn TF, Mullen R. Treating adolescent drug abuse: A comparison of family systems therapy, group therapy, and family drug education. J Marital Fam Ther 1992;18:345-56.
69. Pickrel SG, Henggeler SW. Multisystemic therapy for adolescent substance abuse and dependence. Child Adolesc Psychiatr Clin North Am 1996;5:201-11.
70. Henggeler SW, Pickrel SG, Brondino MJ, et al. Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am J Psychiatry 1996;153:427-8.
71. McGillicuddy NB, Rychtarik RG, Duquette JA, et al. Development of a skill training program for parents of substance-abusing adolescents. J Subst Abuse Treat 2001;20:59-68.
72. Burge SK, Amodei N, Elkin B, et al. An evaluation of two primary care interventions for alcohol abuse among Mexican-American patients. Addiction 1997;92:1705-16.
73. Lewisohn PM, Hopps H, Roberts RE, et al. Adolescent psychopathology I: Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993;102:133-44.
74. Novins DK, Duclos CW, Martin C, et al. Utilization of alcohol, drug, and mental health treatment services among American Indian adolescent detainees. J Am Acad Child Adolesc Psychiatry 1999;38:1102-8.
75. Henggeler SW, Schoenwald SK, Borduin MC, et al. Multisystemic treatment of antisocial behavior in children and adolescents. New York: Guilford; 1988.
76. Myers MG, Stewart DG, Brown SA. Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. Am J Psychiatry 1998;155:479-85.
77. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four year prospective follow up study. J Am Acad Child Adolesc Psychiatry 1997;36:21-9.
78. Riggs PD, Leon SL, Mikulich SK, et al. An open trial of buproprion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolescent Psychiatry 1998; 37:1271-8.
79. Spencer TJ, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996;35:1460-9.
80. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988;45:1023-31.
81. Bremner JD, Southwick SM, Darnell A, et al. Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse. Am J Psychiatry 1996;153:369-75.
82. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990;147:685-95.
83. Weiss L, Fabri A, McCoy K, et al. A vulnerable population in a time of crisis: Drug users and the attacks on the World Trade Center. J Urban Health 2002;79:392-403.
84. Clark DB, Bukstein OG, Smith MG, et al. Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence. Psychiatr Serv 1995;46:618-20.
85. Clark DB, Sayette MA. Anxiety and the development of alcoholism: Clinical and scientific issues. Am J Addictions 1993;2:59-76.
86. Clark DB, Neighbors B. Adolescent substance abuse and internalizing disorders. Child Adolesc Psychiatr Clin North Am 1996;5:45-57.
87. Wilens TE, Biederman J, Millstein RB, et al. Risk for substance use disorder in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 1999;38:680-5.
88. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-8.
89. Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. J Nerv Ment Disord 1987;175:641-52.
90. Drake RE, Xie H, McHugo GJ, et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 2000;26:441-9.
91. Green AI, Burgess ES, Dawson R, et al. Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone. Schizophr Res 2003;60:81-5.
92. Kavanagh DJ, McGrath J, Saunders JB, et al. Substance misuse in patients with schizophrenia: Epidemiology and management. Drugs 2002;62:743-55.
93. Hutchinson KE, Swift R, Rohsenow DJ, et al. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology (Berl) 2001;155:27-34.
94. Brent DA, Perper JA, Allman CJ. Alcohol, firearms, and suicide among youth. JAMA 1987;257:3369-72.
95. Shaffer D, Gould M, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996;53:339-48.
96. Kaminer Y. Adolescent substance abuse treatment: Where do we go from here? Psychiatr Serv 2001;52:147-51.